Historical record - last NADAC effective date: 5/17/2023
Product Information
TELMISARTAN 80 MG TABLET is a generic product labeled by Jubilant Cadista Pharmaceuticals Inc., priced at $0.2685 per EA under NDC 59746044132. Its NADAC has been published 281 times since Jan 10, 2018.
FDA first approved this application on Aug 22, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Telmisartan market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
80 mg/1
Manufacturer
Jubilant Cadista Pharmaceuticals Inc.NDC
59746044132
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
5/17/2023
Active Ingredients
TELMISARTANApproval Type
Generic (ANDA)
FDA Application
ANDA204164FDA Approved
8/22/2016
TE Code
AB
On Market Since
8/22/2016
Pharmacological Classes
Price Statistics
The NADAC for TELMISARTAN 80 MG TABLET has been published 281 times since Jan 10, 2018, and over the history we have for it it has declined 34.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2685 per EA |
|---|---|
| All-time high | $0.6664 (Mar 11, 2020) |
| All-time low | $0.2383 (Jan 18, 2023) |
| Median price | $0.3917 |
| Average price | $0.3984 |
| Largest weekly change | +41.6% (Nov 20, 2019) |
| Weeks tracked | 281 |
| Tracking since | Jan 10, 2018 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
-22.7%
All
-34.5%
Last surveyed May 24, 2023 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 42% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TELMISARTAN 80 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TELMISARTAN 80 MG TABLET, manufactured by Jubilant Cadista Pharmaceuticals Inc., is $0.2685 per EA (NDC 59746044132), effective May 24, 2023.
How has the price of TELMISARTAN 80 MG TABLET changed over time?
Over the history we have for it, the NADAC for TELMISARTAN 80 MG TABLET has declined 34.5%. It has been tracked across 281 weekly CMS publications since Jan 10, 2018.
What are the highest and lowest recorded NADAC prices for TELMISARTAN 80 MG TABLET?
Since Jan 10, 2018, the NADAC for TELMISARTAN 80 MG TABLET has ranged from a low of $0.2383 (Jan 18, 2023) to a high of $0.6664 (Mar 11, 2020), with a median of $0.3917 per EA.
Are there cheaper alternatives to TELMISARTAN 80 MG TABLET?
Yes. 7 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TELMISARTAN 80 MG TABLET, is $0.1563 per EA — about 42% below TELMISARTAN 80 MG TABLET.
Who manufactures TELMISARTAN 80 MG TABLET?
TELMISARTAN 80 MG TABLET (NDC 59746044132) is labeled by Jubilant Cadista Pharmaceuticals Inc., and CMS classifies it as a generic product.